Bilberries reduce low-grade inflammation in individuals with features of metabolic syndrome

Molecular Nutrition and Food Research

Volumn 56, Issue 10, 2012, Pages 1501-1510

  Kolehmainen, Marjukka ^a   Mykkänen, Otto ^a   Kirjavainen, Pirkka V ^a   Leppänen, Tiina ^b   Moilanen, Eeva ^b   Adriaens, Michiel ^c   Laaksonen, David E ^a,d   Hallikainen, Maarit ^a   Puupponen Pimiä, Riitta ^e   Pulkkinen, Leena ^a   Mykkänen, Hannu ^a   Gylling, Helena ^a   Poutanen, Kaisa ^a   Törrönen, Riitta ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Bilberry; Gene expression; Inflammation; Metabolic syndrome

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; POLYPHENOL; TOLL LIKE RECEPTOR;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD; BODY WEIGHT; CHEMISTRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DIET THERAPY; FEMALE; FRUIT; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INFLAMMATION; INTERVENTION STUDY; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; VACCINIUM MYRTILLUS;

ADULT; ANTI-INFLAMMATORY AGENTS; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; C-REACTIVE PROTEIN; DIET; FEMALE; FRUIT; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INTERLEUKIN-12; INTERLEUKIN-6; INTERVENTION STUDIES; LEUKOCYTES, MONONUCLEAR; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYPHENOLS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; VACCINIUM MYRTILLUS;

VACCINIUM MYRTILLUS;

EID: 84867043672     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200195     Document Type: Article

References (49)

1. Lindstrom, J., Peltonen, M., Eriksson, J.G., Louheranta, A. et al., High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia 2006, 49, 912-920.
2. Uusitupa, M., Peltonen, M., Lindstrom, J., Aunola, S. et al., Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study-secondary analysis of the randomized trial. PLoS One 2009, 4, e5656.
3. Kolb, H., Mandrup-Poulsen, T., The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010, 53, 10-20.
4. Shoelson, S. E., Lee, J., Goldfine, A. B., Inflammation and insulin resistance. J. Clin. Invest. 2006, 116, 1793-1801.
5. Libby, P., Ridker, P. M., Hansson, G. K., Leducq transatlantic network on atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 2009, 54, 2129-2138.
6. Ridker, P. M., C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J. Am. Coll. Cardiol. 2007, 49, 2129-2138.
7. Kahn, R., Buse, J., Ferrannini, E., Stern, M., The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005, 48, 1684-1699.
8. Wellen, K. E., Hotamisligil, G. S., Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115, 1111-1119.
9. Musso, G., Gambino, R., Cassader, M., Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu. Rev. Med. 2011, 62, 361-380.
10. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M. et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761-1772.
11. Ghoshal, S., Witta, J., Zhong, J., de Villiers, W. et al., Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 2009, 50, 90-97.
12. Pussinen, P. J., Havulinna, A. S., Lehto, M., Sundvall, J. et al., Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011, 34, 392-397.
13. Hanhineva, K., Torronen, R., Bondia-Pons, I., Pekkinen, J. et al., Impact of dietary polyphenols on carbohydrate metabolism. Int. J. Mol. Sci. 2010, 11, 1365-1402.
14. Hooper, L., Kroon, P. A., Rimm, E. B., Cohn, J. S. et al., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2008, 88, 38-50.
15. Gonzalez-Gallego, J., Garcia-Mediavilla, M. V., Sanchez-Campos, S., Tunon, M. J., Fruit polyphenols, immunity and inflammation. Br. J. Nutr. 2010, 104, S15-S27.
16. Basu, A., Lyons, T. J., Strawberries, blueberries, and cranberries in the metabolic syndrome: clinical perspectives. J. Agric. Food Chem. 2012, 60, 5687-5692.
17. Manach, C., Scalbert, A., Morand, C., Remesy, C. et al. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
18. Ovaskainen, M. L., Torronen, R., Koponen, J. M., Sinkko, H. et al., Dietary intake and major food sources of polyphenols in Finnish adults. J. Nutr. 2008, 138, 562-566.
19. Koponen, J. M., Happonen, A. M., Mattila, P. H., Torronen, A. R., Contents of anthocyanins and ellagitannins in selected foods consumed in Finland. J. Agric. Food Chem. 2007, 55, 1612-1619.
20. Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A. et al., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr. Opin. Cardiol. 2006, 21, 1-6.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285, 2486-2497.
22. Koponen, J. M., Buchert, J., Poutanen, K. S., Törrönen, A. R., Effect of pectinolytic juice production on the extractability and fate of bilberry and black currant anthocyanins. Eur. Food Res. Technol. 2008, 227, 485-494.
23. Koponen, J. M., Happonen, A. M., Auriola, S., Kontkanen, H. et al., Characterization and fate of black currant and bilberry flavonols in enzyme-aided processing. J. Agric. Food Chem. 2008, 56, 3136-3144.
24. Shi, W., Oshlack, A., Smyth, G. K., Optimizing the noise versus bias trade-off for illumina whole genome expression BeadChips. Nucleic Acids Res. 2010, 38, e204.
25. Donath, M. Y., Shoelson, S. E., Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11, 98-107.
26. Paturi, M., Tapanainen, H., Reinivuo, H., Pietinen, P. (Eds.), The National FINDIET 2007 Survey. National Public Health Institute, Helsinki, 2008.
27. Lehtonen, H. M., Suomela, J. P., Tahvonen, R., Yang, B. et al., Different berries and berry fractions have various but slightly positive effects on the associated variables of metabolic diseases on overweight and obese women. Eur. J. Clin. Nutr. 2011, 65, 394-401.
28. Basu, A., Du, M., Leyva, M. J., Sanchez, K. et al., Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J. Nutr. 2010, 140, 1582-1587.
29. Karlsen, A., Paur, I., Bohn, S. K., Sakhi, A. K. et al., Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD. Eur. J. Nutr. 2010, 49, 345-355.
30. Stull, A. J., Cash, K. C., Johnson, W. D., Champagne, C. M.T. et al., Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women. J. Nutr. 2010, 140, 1764-1768.
31. Curtis, P. J., Kroon, P. A., Hollands, W. J., Walls, R. et al., Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. J. Nutr. 2009, 139, 2266-2271.
32. Karlsen, A., Retterstol, L., Laake, P., Paur, I. et al., Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J. Nutr. 2007, 137, 1951-1954.
33. Mattila, P., Hellstrom, J., Torronen, R., Phenolic acids in berries, fruits, and beverages. J. Agric. Food Chem. 2006, 54, 7193-7199.
34. Hellstrom, J. K., Torronen, A. R., Mattila, P. H., Proanthocyanidins in common food products of plant origin. J. Agric. Food Chem. 2009, 57, 7899-7906.
35. Ghanim, H., Abuaysheh, S., Sia, C. L., Korzeniewski, K. et al., Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 2009, 32, 2281-2287.
36. Sautebin, L., Rossi, A., Serraino, I., Dugo, P. et al., Effect of anthocyanins contained in a blackberry extract on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Planta Med. 2004, 70, 745-752.
37. Groeneveld, P. H., Claassen, E., Kuper, C. F., Van Rooijen, N., The role of macrophages in LPS-induced lethality and tissue injury. Immunology 1988, 63, 521-527.
38. Munford, R. S. Detoxifying endotoxin: time, place and person. J. Endotoxin Res. 2005, 11, 69-84.
39. Osto, M., Zini, E., Franchini, M., Wolfrum, C. et al., Subacute endotoxemia induces adipose inflammation and changes in lipid and lipoprotein metabolism in cats. Endocrinology 2011, 152, 804-815.
40. Khovidhunkit, W., Kim, M. S., Memon, R. A., Shigenaga, J. K. et al., Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 2004, 45, 1169-1196.
41. La Cava, A., Matarese, G., The weight of leptin in immunity. Nat. Rev. Immunol. 2004, 4, 371-379.
42. Viardot, A., Lord, R. V., Samaras, K., The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes. J. Clin. Endocrinol. Metab. 2010, 95, 2845-2850.
43. Martinez, H. G., Quinones, M. P., Jimenez, F., Estrada, C. A. et al., Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome. Diabetologia 2011, 54, 2660-2668.
44. Alvehus, M., Buren, J., Sjostrom, M., Goedecke, J. et al., The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring) 2010, 18, 879-883.
45. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y. et al., MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 1999, 189, 1777-1782.
46. Blanco-Colio, L. M., Valderrama, M., Alvarez-Sala, L. A., Bustos, C. et al., Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation 2000, 102, 1020-1026.
47. Miettinen, T. A., Tilvis, R. S., Kesaniemi, Y. A., Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am. J. Epidemiol. 1990, 131, 20-31.
48. Brown, L., Rosner, B., Willett, W. W., Sacks, F. M., Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am. J. Clin. Nutr. 1999, 69, 30-42.
49. Gylling, H., Riikonen, S., Nikkila, K., Savonius, H. et al., Oral guar gum treatment of intrahepatic cholestasis and pruritus in pregnant women: effects on serum cholestanol and other non-cholesterol sterols. Eur. J. Clin. Invest. 1998, 28, 359-363.